je.st
news
's Top Upgrades
2015-04-13 16:05:13| Beverages - Topix.net
Analysts at Goldman Sachs upgraded Clovis Oncology, Inc. from Neutral to Buy. The price target for Clovis Oncology has been raised from $60 to $66.
Tags: top
upgrades
Category:Food and Related Products
Latest from this category |
All news |
||||||||||||||||||||
|
|